Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,462 | 200 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $290.90 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $258.61 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $245.34 | 14 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $222.37 | 12 | $0 (2023) |
| Amgen Inc. | $188.85 | 12 | $0 (2022) |
| Incyte Corporation | $173.23 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $142.44 | 8 | $0 (2024) |
| Eisai Inc. | $139.77 | 8 | $0 (2023) |
| GENZYME CORPORATION | $139.00 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $133.44 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $605.26 | 28 | Merck Sharp & Dohme LLC ($90.49) |
| 2023 | $641.40 | 33 | Merck Sharp & Dohme LLC ($75.68) |
| 2022 | $547.24 | 29 | Amgen Inc. ($76.53) |
| 2021 | $170.77 | 10 | Blueprint Medicines Corporation ($34.13) |
| 2020 | $236.56 | 16 | Pharmacyclics LLC, An AbbVie Company ($46.27) |
| 2019 | $676.42 | 42 | EISAI INC. ($91.32) |
| 2018 | $446.46 | 31 | Daiichi Sankyo Inc. ($89.76) |
| 2017 | $137.80 | 11 | TESARO, Inc. ($32.02) |
All Payment Transactions
200 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: Oncology | ||||||
| 11/15/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: ONCOLOGY | ||||||
| 10/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $27.99 | General |
| 08/06/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Oncology | ||||||
| 06/28/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Oncology | ||||||
| 06/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | Genentech USA, Inc. | Lunsumio (Biological), Polivy | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: BioOncology | ||||||
| 05/24/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: BioOncology | ||||||
| 04/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,645 | 18,048 | $3.3M | $701,530 |
| 2022 | 30 | 1,712 | 19,375 | $3.0M | $634,471 |
| 2021 | 31 | 1,701 | 14,600 | $3.5M | $736,594 |
| 2020 | 29 | 1,760 | 18,124 | $4.0M | $869,928 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 179 | 679 | $998,021 | $176,609 | 17.7% |
| G0340 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | Office | 2023 | 42 | 52 | $397,488 | $97,468 | 24.5% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 197 | 730 | $197,450 | $65,062 | 33.0% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 44 | 47 | $305,265 | $62,188 | 20.4% |
| G0339 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | Office | 2023 | 19 | 19 | $213,940 | $49,411 | 23.1% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 71 | 198 | $186,912 | $33,498 | 17.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 104 | 199 | $150,444 | $29,168 | 19.4% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 35 | 37 | $81,262 | $27,313 | 33.6% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 44 | 63 | $120,385 | $21,586 | 17.9% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 54 | 124 | $103,852 | $21,125 | 20.3% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 30 | 32 | $25,600 | $15,978 | 62.4% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 71 | 140 | $53,943 | $12,694 | 23.5% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 52 | 201 | $100,299 | $12,629 | 12.6% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 51 | 215 | $78,475 | $10,495 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 122 | $17,092 | $7,216 | 42.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 43 | 45 | $21,780 | $6,961 | 32.0% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 47 | 49 | $59,927 | $6,369 | 10.6% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 33 | 33 | $27,588 | $5,893 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $15,348 | $5,828 | 38.0% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 15 | 15 | $16,746 | $4,708 | 28.1% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 53 | 55 | $25,850 | $4,287 | 16.6% |
| 77370 | Special medical radiation therapy consultation | Office | 2023 | 33 | 37 | $21,571 | $3,669 | 17.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 50 | 50 | $12,700 | $3,571 | 28.1% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 15 | 18 | $13,320 | $3,400 | 25.5% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Office | 2023 | 11 | 11 | $17,836 | $3,351 | 18.8% |
About Dr. Guy Savir, MD
Dr. Guy Savir, MD is a Radiation Oncology healthcare provider based in Englewood, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2011. The National Provider Identifier (NPI) number assigned to this provider is 1902105372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guy Savir, MD has received a total of $3,462 in payments from pharmaceutical and medical device companies, with $605.26 received in 2024. These payments were reported across 200 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($3,462).
As a Medicare-enrolled provider, Savir has provided services to 6,818 Medicare beneficiaries, totaling 70,147 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Location Englewood, OH
- Active Since 03/24/2011
- Last Updated 01/07/2022
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1902105372
Products in Payments
- KEYTRUDA (Biological) $258.61
- INJECTAFER (Drug) $234.88
- JAKAFI (Drug) $135.48
- GILOTRIF (Drug) $133.44
- Imbruvica (Drug) $120.66
- Lenvima (Drug) $107.08
- IMBRUVICA (Drug) $101.71
- PLUVICTO (Drug) $90.60
- JEVTANA (Drug) $87.05
- LIBTAYO (Biological) $86.95
- KISQALI (Drug) $77.37
- Kyprolis (Drug) $76.53
- Stivarga (Drug) $71.46
- ERLEADA (Drug) $69.89
- VERZENIO (Drug) $63.11
- ZOLADEX (Drug) $62.28
- Enhertu (Drug) $56.02
- Neulasta (Biological) $55.10
- Rubraca (Drug) $49.72
- Xtandi (Drug) $49.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Englewood
Dr. Gregory Rasp, Md, MD
Radiation Oncology — Payments: $3,982
Mei Zhang, Md, MD
Radiation Oncology — Payments: $3,274
Dr. Douglas Ditzel, Do, DO
Radiation Oncology — Payments: $2,573
Trevor Bluemel, Md, MD
Radiation Oncology — Payments: $1,445
David Dubin, Md, MD
Radiation Oncology — Payments: $1,198
Jeffrey Gilroy, Md, MD
Radiation Oncology — Payments: $873.55